Effects of Ketamine on Human Bladders and Its Possible Mechanisms

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed to evaluate the relationship between ketamine abused and bladder dysfunction and its possible mechanisms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis

NCT04821882

Bladder Pain Syndrome Interstitial Cystitis

COMPLETED NA

Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis

NCT00823030

Interstitial Cystitis

WITHDRAWN NA

COVID-19 Vaccines and the Development of New LUTS

NCT05582525

COVID-19 Vaccine Adverse Reaction Lower Urinary Tract Symptoms

COMPLETED

Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment

NCT01969773

Interstitial Cystitis

COMPLETED PHASE2

Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action

NCT01990898

Interstitial Cystitis

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

case

ketamine + Cystitis

ketamine

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ketamine

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult male or female
* Cystitis (the clinicians ruled out the causes of bacterial infection)
* Frequent micturition
* The clinicians are willing to sign the ICF

Exclusion Criteria

* Suffers from the urinary system disease, is not suitable to carry on the urinary bladder biopsy sampling
* Suffers from other diseases, doctor recognized that is not suitable to carry on the sampling
* The clinicians are not willing to sign the ICF

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes